Authors:
CALIENDO G
FIORINO F
GRIECO P
PERISSUTTI E
RAMUNNO A
SANTAGADA V
ALBRIZIO S
CALIFANO D
GIULIANO A
SANTELLI G
Citation: G. Caliendo et al., PHENOL-DERIVED CVFM ANALOG INHIBITORS OF RAS FARNESYLTRANSFERASE POSSESSING CELLULAR IN-VITRO ACTIVITY, European journal of medicinal chemistry, 33(9), 1998, pp. 725-732
Authors:
CALIFANO D
MONACO C
SANTELLI G
GIULIANO A
VERONESE ML
BERLINGIERI MT
DEFRANCISCIS V
BERGER N
TRAPASSO F
SANTORO M
VIGLIETTO G
FUSCO A
Citation: D. Califano et al., THYMOSIN BETA-10 GENE OVEREXPRESSION CORRELATED WITH THE HIGHLY MALIGNANT NEOPLASTIC PHENOTYPE OF TRANSFORMED THYROID-CELLS IN-VIVO AND IN-VITRO, Cancer research, 58(4), 1998, pp. 823-828
Authors:
DENIGRIS F
VISCONTI R
CERUTTI J
CALIFANO D
MINEO A
SANTORO M
SANTELLI G
FUSCO A
Citation: F. Denigris et al., OVEREXPRESSION OF THE HIP GENE CODING FOR A HEPARIN HEPARAN SULFATE-BINDING PROTEIN IN HUMAN THYROID CARCINOMAS/, Cancer research, 58(20), 1998, pp. 4745-4751
Authors:
VIGLIETTO G
ROMANO A
MANZO G
CHIAPPETTA G
PAOLETTI I
CALIFANO D
GALATI MG
MAURIELLO V
BRUNI P
LAGO CT
FUSCO A
PERSICO VG
Citation: G. Viglietto et al., UP-REGULATION OF THE ANGIOGENIC FACTORS PLGF, VEGF AND THEIR RECEPTORS (FLT-1, FLK-1 KDR) BY TSH IN CULTURED THYROCYTES AND IN THE THYROID-GLAND OF THIOURACIL-FED RATS SUGGEST A TSH-DEPENDENT PARACRINE MECHANISM FOR GOITER HYPERVASCULARIZATION/, Oncogene, 15(22), 1997, pp. 2687-2698
Authors:
CHIAPPETTA G
FABIEN N
PICONE A
CALIFANO D
MONACO C
DEFRANCISCIS V
VECCHIO G
SANTELLI G
Citation: G. Chiappetta et al., TRANSGENIC MICE CARRYING THE HUMAN KRAS ONCOGENE UNDER THE CONTROL OFA THYROGLOBULIN PROMOTER - KRAS EXPRESSION IN THYROIDS ANALYZED BY IN-SITU HYBRIDIZATION, Oncology research, 8(2), 1996, pp. 85-93
Authors:
VIGLIETTO G
ROMANO A
MAGLIONE D
RAMBALDI M
PAOLETTI I
LAGO CT
CALIFANO D
MONACO C
MINEO A
SANTELLI G
MANZO G
BOTTI G
CHIAPPETTA G
PERSICO MG
Citation: G. Viglietto et al., NEOVASCULARIZATION IN HUMAN GERM-CELL TUMORS CORRELATES WITH A MARKEDINCREASE IN THE EXPRESSION OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR BUT NOT THE PLACENTA-DERIVED GROWTH-FACTOR, Oncogene, 13(3), 1996, pp. 577-587
Authors:
SALVATORE D
CELETTI A
FABIEN N
PAULIN C
MARTELLI ML
BATTAGLIA C
CALIFANO D
MONACO C
VIGLIETTO G
SANTORO M
FUSCO A
Citation: D. Salvatore et al., LOW-FREQUENCY OF P53 MUTATIONS IN HUMAN THYROID-TUMORS - P53 AND RAS MUTATION IN 2 OUT OF 56 THYROID-TUMORS, European journal of endocrinology, 134(2), 1996, pp. 177-183
Authors:
CALIFANO D
DALESSIO A
COLUCCIDAMATO GL
DEVITA G
MONACO C
SANTELLI G
DIFIORE PP
VECCHIO G
FUSCO A
SANTORO M
DEFRANCISCIS V
Citation: D. Califano et al., A POTENTIAL PATHOGENETIC MECHANISM FOR MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 SYNDROMES INVOLVES RET-INDUCED IMPAIRMENT OF TERMINAL DIFFERENTIATION OF NEUROEPITHELIAL CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(15), 1996, pp. 7933-7937
Authors:
RIZZO C
CALIFANO D
COLUCCIDAMATO GL
DEVITA G
DALESSIO A
DATHAN NA
FUSCO A
MONACO C
SANTELLI G
VECCHIO G
SANTORO M
DEFRANCISCIS V
Citation: C. Rizzo et al., LIGAND STIMULATION OF A RET CHIMERIC RECEPTOR CARRYING THE ACTIVATINGMUTATION RESPONSIBLE FOR THE MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B, The Journal of biological chemistry, 271(46), 1996, pp. 29497-29501
Authors:
CALIFANO D
MONACO C
DEVITA G
DALESSIO A
DATHAN NA
POSSENTI R
VECCHIO G
FUSCO A
SANTORO M
DEFRANCISCIS V
Citation: D. Califano et al., ACTIVATED RET PTC ONCOGENE ELICITS IMMEDIATE-EARLY AND DELAYED-RESPONSE GENES IN PC12 CELLS/, Oncogene, 11(1), 1995, pp. 107-112
Authors:
MONACO C
CALIFANO D
CHIAPPETTA G
MINEO A
DEFRANCISCIS V
VECCHIO G
SANTELLI G
Citation: C. Monaco et al., MUTATED HUMAN KIRSTEN RAS, DRIVEN BY A THYROGLOBULIN PROMOTER, INDUCES A GROWTH ADVANTAGE AND PARTIALLY DEDIFFERENTIATES RAT-THYROID EPITHELIAL-CELLS IN-VITRO, International journal of cancer, 63(5), 1995, pp. 757-760
Authors:
SANTELLI G
DEFRANCISCIS V
PORTELLA G
CHIAPPETTA G
DALESSIO A
CALIFANO D
ROSATI R
MINEO A
MONACO C
MANZO G
POZZI L
VECCHIO G
Citation: G. Santelli et al., PRODUCTION OF TRANSGENIC MICE EXPRESSING THE KI-RAS ONCOGENE UNDER THE CONTROL OF A THYROGLOBULIN PROMOTER, Cancer research, 53(22), 1993, pp. 5523-5527